Factors Associated With In-Hospital Mortality and Length of Stay Among Hospitalised Patients Receiving Carbapenem Therapy: A Retrospective Cohort Study.
- 1Department of Pharmacy Shah Alam Hospital Shah Alam Selangor Malaysia.
- 2School of Pharmacy IMU University Kuala Lumpur Malaysia imu.edu.my.
- 3School of Applied Sciences University of Huddersfield Huddersfield UK hud.ac.uk.
Abstract
Background
Patients receiving carbapenems are clinically heterogeneous and have severe infections and multiple comorbidities. Evidence on factors associated with mortality and length of stay (LOS) in this treatment-defined population remains limited.Methods
This retrospective cohort study included adult hospital episodes involving at least one carbapenem dose at Hospital Shah Alam during 2025. Firth penalised logistic regression was used for in-hospital mortality, and median regression with 2000 bootstrap resamples was used for right-skewed LOS. Covariates were selected a priori. Carbapenem continuation beyond 72 h was treated as a postbaseline characteristic and was not included in outcome models.Results
Among 112 eligible episodes involving 107 patients, 38 deaths occurred (33.9%); median LOS was 19.0 days (IQR: 10.8-28.0). Older age (adjusted OR: 1.41 per 10 years, 95% CI: 1.07-1.92) and definitive indication at carbapenem initiation (adjusted OR: 0.28, 95% CI: 0.10-0.70) were associated with in-hospital mortality. Hospital-acquired infection was associated with a longer adjusted median LOS (median difference 8.63 days, 95% bootstrap CI: 0.50-14.44). Definitive indication was not clearly associated with LOS after adjustment (median difference -5.54 days, 95% bootstrap CI: -12.00-4.62).Conclusions
Older age and definitive indication at carbapenem initiation were associated with in-hospital mortality, while hospital-acquired infection was associated with longer median LOS. The treatment-indication association should not be interpreted causally because residual confounding, particularly by acute illness severity and indication, remains likely.
Related
- Clinical factors associated with carbapenem resistance and in-hospital mortality in Klebsiella pneumoniae bloodstream infection: a 7-year retrospective cohort study
- Does receiving red yeast rice prescriptions (LipoCol Forte®) increase the risk of end-stage renal disease or not? A retrospective cohort study
- A pretreatment hormonal-nutritional-immune score for locally advanced gastric cancer receiving neoadjuvant immunochemotherapy: a multicenter retrospective cohort study
- Prevalence of intestinal parasites and associated factors among HIV patients receiving antiretroviral therapy at public hospitals in North Shoa Zone, Oromia, Ethiopia: Cross-sectional study
- Socioeconomic deprivation and postoperative mortality: a retrospective analysis of prospectively collected data
BibTeX
@article{zaihan2026factors,
title = {{Factors Associated With In-Hospital Mortality and Length of Stay Among Hospitalised Patients Receiving Carbapenem Therapy: A Retrospective Cohort Study.}},
author = {Abdullah Faiz Zaihan and Dhivyaa K Ganesan and Chia Siang Kow},
journal = {Interdisciplinary perspectives on infectious diseases},
year = {2026},
month = oct,
doi = {10.1155/ipid/7227340},
url = {https://europepmc.org/article/MED/42899063},
note = {CC BY},
}
RIS
TY - JOUR
TI - Factors Associated With In-Hospital Mortality and Length of Stay Among Hospitalised Patients Receiving Carbapenem Therapy: A Retrospective Cohort Study.
AU - Abdullah Faiz Zaihan
AU - Dhivyaa K Ganesan
AU - Chia Siang Kow
PY - 2026
DA - 2026/10/19
JO - Interdisciplinary perspectives on infectious diseases
DO - 10.1155/ipid/7227340
UR - https://europepmc.org/article/MED/42899063
AB - Background Patients receiving carbapenems are clinically heterogeneous and have severe infections and multiple comorbidities. Evidence on factors associated with mortality and length of stay (LOS) in this treatment-defined population remains limited.Methods This retrospective cohort study included adult hospital episodes involving at least one carbapenem dose at Hospital Shah Alam during 2025. Firth penalised logistic regression was used for in-hospital mortality, and median regression with 2000 bootstrap resamples was used for right-skewed LOS. Covariates were selected a priori. Carbapenem continuation beyond 72 h was treated as a postbaseline characteristic and was not included in outcome models.Results Among 112 eligible episodes involving 107 patients, 38 deaths occurred (33.9%); median LOS was 19.0 days (IQR: 10.8-28.0). Older age (adjusted OR: 1.41 per 10 years, 95% CI: 1.07-1.92) and definitive indication at carbapenem initiation (adjusted OR: 0.28, 95% CI: 0.10-0.70) were associated with in-hospital mortality. Hospital-acquired infection was associated with a longer adjusted median LOS (median difference 8.63 days, 95% bootstrap CI: 0.50-14.44). Definitive indication was not clearly associated with LOS after adjustment (median difference -5.54 days, 95% bootstrap CI: -12.00-4.62).Conclusions Older age and definitive indication at carbapenem initiation were associated with in-hospital mortality, while hospital-acquired infection was associated with longer median LOS. The treatment-indication association should not be interpreted causally because residual confounding, particularly by acute illness severity and indication, remains likely.
SN - 1687-708X
SN - 1687-7098
ER -